The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma-Reference-Cited by-同舟云学术

The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma

Published:2019-09-09 Issue:6 Volume:85 Page:E1095-E1110
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurg.

Author:

Zou Ming-Xiang,Zheng Bo-Wen,Liu Fu-Sheng,Wang Xiao-Bin,Hu Jia-Rui,Huang Wei,Dai Zhe-Hao,Zhang Qian-Shi,Liu Fu-Bing,Zhong Hua,Jiang Yi,She Xiao-Ling,Li Xiao-Bing,Lv Guo-Hua,Li Jing

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/85/6/E1095/30659672/nyz333.pdf

Reference80 articles.

1. Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases;Samson;J Bone Joint Surg Am,1993

2. Chordoma: current concepts, management, and future directions;Walcott;Lancet Oncol,2012

3. Chordoma: incidence and survival patterns in the United States, 1973–1995;McMaster;Cancer Causes Control,2001

4. Chordoma: the nonsarcoma primary bone tumor;Chugh;Oncologist,2007

5. A review of the surgical management of sacral chordoma;Kayani;Eur J Surg Oncol,2014

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone;Cancer;2024-09-06

2. Hypoxic Upregulation of IER2 Increases Paracrine GMFG Signaling of Endoplasmic Reticulum Stress‐CAF to Promote Chordoma Progression via Targeting ITGB1;Advanced Science;2024-08-29

3. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone;JCO Precision Oncology;2024-08

4. The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment;Journal of Orthopaedic Surgery and Research;2024-07-15

5. Immune microenvironment and immunotherapy for chordoma;Frontiers in Oncology;2024-06-24